
Transitioning from conformal radiotherapy to intensity-modulated radiotherapy after radical prostatectomy: Clinical benefit, oncologic outcomes and incidence of gastrointestinal and urinary toxicities
Author(s) -
Christian H. Flores-Balcázar,
D.M. Urías-Arce,
María T. Bourlon,
Fernando Gabilondo-Navarro,
Sandra Ileana Pérez-Álvarez,
Rubí Ramos-Prudencio,
Francisco Rodríguez-Covarrubias
Publication year - 2020
Publication title -
reports of practical oncology and radiotherapy
Language(s) - English
Resource type - Journals
eISSN - 2083-4640
pISSN - 1507-1367
DOI - 10.1016/j.rpor.2020.04.018
Subject(s) - medicine , radiation therapy , prostate cancer , prostatectomy , toxicity , genitourinary system , urology , oncology , radiology , cancer
The purpose of this study was to review genitourinary (GU) and gastrointestinal (GI) toxicity associated with high-dose radiotherapy (RT) delivered with 3-dimensional conformal radiotherapy (3D-CRT) and intensity-modulated radiotherapy (IMRT) or volumetric arc therapy (VMAT) following radical prostatectomy (RP).